Article Details
Retrieved on: 2022-08-12 20:21:16
Tags for this article:
Click the tags to see associated articles and topics
Excerpt
- August 12, 2022 - Vigil Neuroscience, Inc. (Nasdaq: VIGL), a clinical-stage biotechnology company committed to harnessing the power of microglia for ...
Article found on: www.marketscreener.com
This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.
Sign UpAlready have an account? Log in here